Personalized immune cells target advanced prostate cancer in new trial
Disease control
Recruiting now
This trial is testing whether modified immune cells can help control advanced prostate cancer that has stopped responding to standard hormone treatments. Doctors take a patient's own immune cells, modify them to recognize prostate cancer proteins, and infuse them back into the bo…
Phase: PHASE1, PHASE2 • Sponsor: Arsenal Biosciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC